ArticleThe Journal of clinical investigation2020

Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy.

Nikita S Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.